by nikki mann | Aug 3, 2022 | News
Our first ever hybrid Therapeutics Symposium was held at the end of June and we were thrilled to welcome over 350 delegates at West Road Concert Hall, with a further 200+ delegates opting to view the talks via the online symposium platform! A selection of photographs...
by nikki mann | Jul 15, 2022 | News
CardiaTec, a company co-founded by Milner Head of Computational Biology Dr Namshik Han, has secured £1.4 million pre-seed investment to combat cardiovascular diseases using artificial intelligence (AI). CardiaTec is developing a target discovery platform for analysing...
by nikki mann | Jul 7, 2022 | News
The CEO Today Business Women of the Year Awards 2022 edition has been published this week, and we’re delighted that Milner Deputy Director Kathryn Chapman has been announced as an awardee. Dedicated to recognising the achievements of today’s female leaders and...
by nikki mann | May 26, 2022 | News
We are thrilled to announce that the Milner collaboration with the medical research charity LifeArc has been expanded into a 5-year strategic partnership until 2026. The Milner Computational Research team, led by Namshik Han, have been collaborating closely with the...
by nikki mann | May 12, 2022 | News
We are honoured to have been announced as highly commended in the Innovation category of the 2022 Cambridge Independent Science & Technology Awards. Milner Director Kathryn Chapman was presented with the trophy at the awards ceremony held last night. Several...
by nikki mann | Mar 24, 2022 | News
We are delighted that the Milner Therapeutics Institute has been announced as a finalist for the Award for Innovation in the 2021-2022 Cambridge Independent Science and Technology Awards. Now in their fifth year, these awards showcase a vast range of talent throughout...
